This Equifax Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Equifax Inc.
Builders FirstSource, Inc.
Parsons
NUVATION BIO INC
Innovus Pharmaceuticals, Inc.
Equifax Inc. EFX | 0.00 | |
Builders FirstSource, Inc. BLDR | 0.00 | |
Parsons PSN | 0.00 | |
NUVATION BIO INC NUVB | 0.00 | |
Innovus Pharmaceuticals, Inc. INNV | 0.00 |
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Baird analyst Andrew Wittmann upgraded Parsons Corp (NYSE:PSN) from Neutral to Outperform and raised the price target from $48 to $57. Parsons closed at $46.06 on Thursday. See how other analysts view this stock.
- Keybanc analyst Matthew Gillmor upgraded InnovAge Holding Corp (NASDAQ:INNV) from Sector Weight to Overweight and announced a $13 price target. InnovAge shares closed at $10.72 on Thursday. See how other analysts view this stock.
- Rothschild & Co analyst Simon Clinch upgraded Equifax Inc (NYSE:EFX) from Neutral to Buy and raised the price target from $214 to $235. Equifax closed at $192.41 on Thursday. See how other analysts view this stock.
- JP Morgan analyst Tomohiko Sano upgraded TIC Solutions Inc (NYSE:TIC) from Underweight to Neutral and raised the price target from $9 to $11. TIC Solutions shares closed at $9.02 on Thursday. See how other analysts view this stock.
- Morgan Stanley analyst Carlos De Alba upgraded Ternium S.A. (NYSE:TX) from Equal-Weight to Overweight and raised the price target from $55 to $65. Ternium closed at $54.21 on Thursday. See how other analysts view this stock.
Considering buying EFX stock? Here’s what analysts think:
Photo via Shutterstock